Doxycycline ameliorates ischemic and Border-Zone remodeling and endothelial dysfunction after myocardial infarction in rats

Journal of Heart and Lung Transplantation

Volumn 23, Issue 6, 2004, Pages 729-736

  Camp, Teresa M ^a   Tyagi, Sam C ^a   Aru, Giorgio M ^b   Hayden, Melvin R ^a   Mehta, Jay L ^c   Tyagi, Suresh C ^a  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BRADYKININ; DOXYCYCLINE; GELATINASE B; MATRIX METALLOPROTEINASE; NITRIC OXIDE; NITROPRUSSIDE SODIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; ENZYME ACTIVITY; HEART CONTRACTION; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STATISTICAL SIGNIFICANCE; SURGICAL TECHNIQUE; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; CARDIOTONIC AGENTS; DOXYCYCLINE; ENDOCARDIUM; HYDROXYPROLINE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MYOCARDIAL INFARCTION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE INHIBITOR OF METALLOPROTEINASES; VENTRICULAR REMODELING;

EID: 2642580639     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2003.06.005     Document Type: Article

References (36)

1. Tyagi S.C., Campbell S.E., Reddy H.K., Tjahja E., Voelker D.J. Matrix metalloproteinase activity expression in infarcted, noninfarcted and dilated cardiomyopathic human hearts. Mol Cell Biochem. 155:1996;13-21
2. Tyagi S.C., Kumar S.G., Haas S.J., et al. Post-transcriptional regulation of matrix metalloproteinase in human heart end-stage failure secondary to ischemic cardiomyopathy. J Mol Cell Cardiol. 28:1996;1415-1428
3. Bernstein M., Tyagi S.C. β-blocker improves cardiac function by reducing oxidative stress and metalloproteinase activity post myocardial infarction. J Appl Res. 1:2001;149-157
4. Hoppeler H., Kayar S.R. Capillary and oxidative capacity of muscles. News Physiol Sci. 3:1988;113-116
5. Roberts J.T., Wearn J.T. Quantitative changes in the capillary-muscle relationship in human hearts during normal growth and hypertrophy. Am Heart J. 16:1941;617-633
6. Henderson A.H., Lewis M.J., Shah A.M., Smith J.A. Endothelium, endocardium, and cardiac contraction. Cardiovasc Res. 26:1992;305-308
7. Smith J.A., Shah A.M., Fort S., Lewis M.J. The influence of endocardial endothelium on myocardial contraction. Trends Pharmacol Sci. 13:1992;113-116
8. Mebazaa A., Wetzel R., Cherian M., Abraham M. Comparison between endothelial and great vessel endothelial cells Morphology, growth, and prostaglandin release. Am J Physiol. 268:1995;H250-259
9. Pinsky D.J., Patton S., Mesaros S., et al. Mechanical transduction of NO synthesis in the beating heart. Circ Res. 81:1997;372-379
10. Gattuso A., Mazza R., Pellegrino D., Tota B. Endocardial endothelium (EE) mediates luminal acetylcholine-nitric oxide signaling in isolated frog heart. Am J Physiol. 276:1999;H633-641
11. Wang J., Morgan J.P. EE modulates myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Cir Res. 70:1992;754-760
12. Hunt M.J., Aru G.M., Hayden M.R., Moore C.K., Hoit B.D., Tyagi S.C. Induction of oxidative stress and disintegrin metalloproteinase in human heart end-stage failure. Am J Physiol. 283:2002;L239-245
13. Cox M., Sood H., Hunt M., et al. Apoptosis in the left ventricle of chronic volume overload causes endocardial endothelial dysfunction in rats. Am J Physiol. 282:2002;H1197-1205
14. Grenier D., Plamondon P., Sorsa T., et al. Inhibition of proteolytic, serpinolytic, and progelatinase-b activation activities of periodontopathogens by doxycycline and the non-antimicrobial chemically modified tetracycline derivatives. J Periodontol. 73:2002;79-85
15. Tyagi S.C., Kumar S.G., Alla S.R., Reddy H.K., Voelker D.J., Janicki J.S. Extracellular matrix regulation of metalloproteinase and antiproteinase in human heart fibroblast cells. J Cell Physiol. 167:1996;137-147
16. Smith J.R., Gabler W.L. Protective effects of doxycycline in mesenteric ischemia and reperfusion. Res Commun Mol Pathol Pharmacol. 88:1995;303-315
17. Buelke S.J., Holson J.F., Bazare J.J., Young J.F. Comparative stability of physiological parameters during sustained anesthesia in rats. Lab Anim Sci. 28:1978;157-162
18. Tyagi S.C., Kumar S.G., Cassatt S., Parker J.L. Temporal expression of extracellular matrix metalloproteinase and tissue plasminogen activator in the development of collateral vessels in canine model of coronary occlusion. Can J Physiol Pharmacol. 74:1996;983-995
19. Mujumdar V.S., Tyagi S.C. Temporal regulation of extracellular matrix components in transition from compensatory hypertrophy to decompensatory heart failure. J Hypertension. 17:1999;261-270
20. Tyagi S.C., Ratajska A., Weber K.T. Myocardial matrix metalloproteinases Localization and activation. Mol Cell Biochem. 126:1993;49-59
21. Mujumdar V.S., Smiley L.M., Tyagi S.C. Activation of matrix metalloproteinase dilates and decreases cardiac tensile strength. Intern J Cardiol. 79:2001;277-286
22. Tyagi S.C., Smiley L.M., Mujumdar V.S. Homocysteine impairs endocardial endothelial function. Can J Physiol Pharmacol. 77:1999;95-97
23. Sys S., Pellegrino D., Mazza R., et al. EE in the avascular heart of the frog Morphology and role of NO. J Exp Biol. 200:1997;3109-3118
24. Wang J., Morgan J.P. EE modulates myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Cir Res. 70:1992;754-760
25. Miller A., Mujumdar V., Palmer L., Bower J.D., Tyagi S.C. Reversal of EE dysfunction by folic acid in homocystinemic hypertensive rats. Am J Hyperten. 15:2002;157-163
26. Tarone R.E. A modified Bonferroni method for discrete data. Biometrics. 46:1990;515
27. Cheung P.Y., Sawicki G., Wozniak M., Wang W., Radomski M.W., Schulz R. Matrix metalloproteinase-2 contributes to ischemia-reperfusion injury in the heart. Circulation. 101:2000;1833-1839
28. Aimes R.T., Quigley J.P. MMP-2 is an interstitial collagenase. J Biol Chem. 270:1995;5872-5876
29. Senior R.M., Griffin G.L., Eliszar C.J., Shapiro S.D., Goldberg G.I., Welgus H.G. Human 92- and 72- kilodalton type IV collagenases are elastases. J Biol Chem. 266:1991;7870-7875
30. Rucklidge G.J., Milne G., McGaw B.A., Milne E., Robins S.P. Turnover rates of different collagen types measured by isotope ratio mass spectrometry. Biochim Biophys Acta. 11:1992;1156-1157
31. Romanic A.M., Harrison S.M., Bao W., et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of MMP-9. Cardiovasc Res. 54:2002;495-498
32. Faury G., Ristori M.T., Verdetti J., Jacob M.P., Robert L. Effect of elastin peptides on vascular tone. J Vasc Res. 32:1995;112-119
33. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. Circulation. 94:1996;258-265
34. Tajima M., Weinberg E.O., Bartunek J., et al. Treatment with growth hormone enhances contractile reserve and intracellular calcium transients in myocytes from rats with postinfarction heart failure. Circulation. 99:1999;127-134
35. Gelzer A., Morse N.S., Dries M. Heart rate dependency of T wave polarity in the horse. J Vet Internal Med. 11:1997;107
36. Tyagi S.C. Physiology and homeostasis of ECM Cardiovascular adaptation and remodeling. Pathophysiology. 7:2000;177-182